The consultation-liaison (CL) psychiatrist is consulted fairly often for problems related to pain. This may vary substantially, however, depending on the presence of pain specialists from other disciplines, typically anesthesiology, and the CL psychiatrist’s interest in and comfort with pain problems. If the CL psychiatrist accepts these consults, however, and is considered knowledgeable, requests for help will be frequent.


Chronic Pain Pain Medication Complex Regional Pain Syndrome Chronic Pain Patient Opioid Dependence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anooshian J, Streltzer J, Goebert D. Effectiveness of a psychiatric pain clinic. Psychosomatics 1999;40:226–232.PubMedGoogle Scholar
  2. Ballantyne J, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943–1953.PubMedCrossRefGoogle Scholar
  3. Breivik H, Rennemo F. Clinical evaluation of combined treatment with methadone and psychotropic drugs in cancer patients. Acta Anaesth Scand Suppl 1982;74:135–140.CrossRefGoogle Scholar
  4. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 2000;20:237–245.PubMedCrossRefGoogle Scholar
  5. Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients Pain 2001;90:91–96.Google Scholar
  6. Drug Abuse Warning Network. Narcotic analgesics, 2002 update. 2004. Available on the web at
  7. Engel GL. Psychogenic pain and pain-prone patient. Am J Med 1959;26:899–918.PubMedCrossRefGoogle Scholar
  8. Gorman AL, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett 1997;223:5–8.PubMedCrossRefGoogle Scholar
  9. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986;25:297–312.PubMedCrossRefGoogle Scholar
  10. Ibuki T, Dunbar SA, Yaksh TL. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain 1997;70:125–132.PubMedCrossRefGoogle Scholar
  11. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000;19:53–62.PubMedCrossRefGoogle Scholar
  12. King T, Gardell LR, Wang R, et al. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 2005;116:276–288.PubMedCrossRefGoogle Scholar
  13. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973;78:173–181.PubMedGoogle Scholar
  14. Mercadante S, Sapio M, Serretta R, Caligara M. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Ann Oncol 1996;7:613–617.PubMedGoogle Scholar
  15. Morbidity and Mortality Weekly Report. Increase in poisoning deaths caused by non-illicit drugs-Utah. MMWR 2005;54(2):33–36.Google Scholar
  16. Nestler EJ. Molecular neurobiology of addiction. Am J Addict 2001;10:201–217.PubMedCrossRefGoogle Scholar
  17. Newman RI, Seres JL, Yospe LP, Garlington B. Multidisciplinary treatment of chronic pain: long-term follow-up of low-back pain patients. Pain 1978;4:283–292.PubMedCrossRefGoogle Scholar
  18. O’Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K. The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain 2000;85:209–215.PubMedCrossRefGoogle Scholar
  19. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171–186.PubMedCrossRefGoogle Scholar
  20. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003;14;289:2370–2378.CrossRefGoogle Scholar
  21. Schreiber S, Backer MM, Weizman R, Pick CG. Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. Neurosci Lett 1997;228:25–28.PubMedCrossRefGoogle Scholar
  22. Stinus L, Allard M, Gold L, Simmonet G. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides 1995;16:1235–1241.PubMedCrossRefGoogle Scholar
  23. Streltzer J. Chronic pain and addiction. In: Leigh H, ed. Consultation-Liaison Psychiatry: 1990 and Beyond. New York: Plenum Press, 1994:43–51.Google Scholar
  24. Streltzer J, Eliashof BA, Kline AE, Goebert D. Chronic pain disorder following physical injury. Psychosomatics 2000;41:227–234.PubMedCrossRefGoogle Scholar
  25. Streltzer J, Johansen L: Prescription drug dependence and evolving beliefs about pain management. Am J Psychiatry 2006;163:594–598.PubMedCrossRefGoogle Scholar
  26. Streltzer J. Pain Management in the Opioid-dependent Patient. Current Psychiatry Reports 2001;3:489–496.PubMedCrossRefGoogle Scholar
  27. Streltzer J. Treatment of iatrogenic drug dependence in the general hospital. Gen Hosp Psychiatry 1980;2:262–266.PubMedCrossRefGoogle Scholar
  28. Streltzer J, Wade TC. Cultural factors in the undertreatment of postoperative pain. Psychosom Med 1981;43:397–403.PubMedGoogle Scholar
  29. Vanderah TW, Gardell LR, Burgess SE, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000;20:7074–7079.PubMedGoogle Scholar
  30. Verebely K, Volavka J, Mule S, Resnick R. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clinical Pharmacology and Therapeutics 1975;18:180–190.PubMedGoogle Scholar
  31. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain 2004;109:207–209.CrossRefGoogle Scholar
  32. Xie J, Herman D, Stiller C, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005;25:409–416.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Jon Streltzer
    • 1
  1. 1.Department of PsychiatryUniversity of HawaiiHonoluluUSA

Personalised recommendations